Page 5,912«..1020..5,9115,9125,9135,914..5,9205,930..»

Hospital of the University of Pennsylvania Receives Advanced Certification for Comprehensive Stroke Centers from The …

Posted: Published on January 3rd, 2013

PHILADELPHIA The Hospital of the University of Pennsylvania (HUP) has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commissions standards for Disease-Specific Care Comprehensive Stroke Center Certification, becoming the first center in Philadelphia and among a select few hospitals in the United States to be named as part of an elite group of providers focused on complex stroke care. Comprehensive Stroke Centers are recognized as industry leaders and are responsible for setting the national agenda in highly-specialized stroke care. In September 2012, The Joint Commission, in collaboration with the American Heart Association/ American Stroke Associations Brain Attack Coalition, launched the Advanced Certification for Comprehensive Stroke Centers (CSCs). The Hospital of the University of Pennsylvania underwent a rigorous onsite review in October 2012. Joint Commission experts reviewed HUPs compliance with the Comprehensive Stroke Center standards and requirements including advanced imaging capabilities, 24/7 availability of specialized treatments, and staff with the unique education and competencies to care for complex stroke patients. This accomplishment is truly a result of multidisciplinary and multi-departmental collaboration, as this new level of certification recognizes the significant resources in staff and training that comprehensive stroke centers must have … Continue reading

Comments Off on Hospital of the University of Pennsylvania Receives Advanced Certification for Comprehensive Stroke Centers from The …

HUP Receives Comprehensive Stroke Center Certification

Posted: Published on January 3rd, 2013

Hospital of the University of Pennsylvania Receives Advanced Certification for Comprehensive Stroke Centers from The Joint Commission and AHA/ASA HUP Becomes First Hospital in Philadelphia to Earn Comprehensive Stroke Center Status Newswise PHILADELPHIA The Hospital of the University of Pennsylvania (HUP) has been recognized by The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) as meeting The Joint Commissions standards for Disease-Specific Care Comprehensive Stroke Center Certification, becoming the first center in Philadelphia and among a select few hospitals in the United States to be named as part of an elite group of providers focused on complex stroke care. Comprehensive Stroke Centers are recognized as industry leaders and are responsible for setting the national agenda in highly-specialized stroke care. In September 2012, The Joint Commission, in collaboration with the American Heart Association/ American Stroke Associations Brain Attack Coalition, launched the Advanced Certification for Comprehensive Stroke Centers (CSCs). The Hospital of the University of Pennsylvania underwent a rigorous onsite review in October 2012. Joint Commission experts reviewed HUPs compliance with the Comprehensive Stroke Center standards and requirements including advanced imaging capabilities, 24/7 availability of specialized treatments, and staff with the unique education and competencies to care for complex stroke … Continue reading

Comments Off on HUP Receives Comprehensive Stroke Center Certification

Q Therapeutics to Present at Biotech Showcase(TM) 2013 to Be Held During JP Morgan Healthcare Conference in San …

Posted: Published on January 3rd, 2013

SALT LAKE CITY, UT--(Marketwire - Jan 3, 2013) - Q Therapeutics, Inc., an emerging biotechnology company developing innovative cell therapy products for the treatment of debilitating diseases of the central nervous system, today announced that the Company is scheduled to present at the Biotech Showcase 2013 to be held next week in San Francisco, California, January 7-9, 2013, during the JP Morgan Healthcare Conference. The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. EVENT AT A GLANCE WHO: Deborah Eppstein, PhD - President and CEO Steve Borst - CFO and Vice President, Corporate Development WHEN: Regenerative Medicine Track Tuesday, January 8, 2013 11:00 AM PT WHERE: Parc 55 Wyndham San Francisco - Union Square 55 Cyril Magnin Street San Francisco, California NOTE TO PRESS:Qualified media are also invited to attend the event on a complimentary basis.Please contact Justine Griego from EBD Group at 760-930-0500 or jgriego@ebdgroup.com to register for the event.To arrange one-on-one interviews with the executive management team of … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Q Therapeutics to Present at Biotech Showcase(TM) 2013 to Be Held During JP Morgan Healthcare Conference in San …

InVivo Therapeutics Co-Founder Robert S. Langer to be Awarded National Medal of Technology and Innovation by President …

Posted: Published on January 3rd, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today congratulates Robert S. Langer, ScD, InVivo co-founder and member of the Companys scientific advisory board, on receiving the National Medal of Technology and Innovation. President Barack Obama will present the award to Dr. Langer, who also won the National Medal of Science in 2006, at a White House ceremony in early 2013. Dr. Langer, the David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT), is among 23 renowned researchers who have been awarded the nations highest honors for scientists, engineers, and inventors this year. With this award, he joins the ranks of five engineers and inventors from MIT who have earned the same honor, and becomes one of three Americans to have won both the National Medal of Science and the National Medal of Technology and Innovation. The impact of Bobs biomaterials research and drug/cell delivery innovations are enormous, and his discoveries have now led to over 55 products either currently in clinical trials or already approved by the FDA, said InVivo Chief Executive Officer Frank Reynolds. The range of Bobs … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Co-Founder Robert S. Langer to be Awarded National Medal of Technology and Innovation by President …

Research and Markets: How Selegiline ((-)-Deprenyl) Slows Brain Aging

Posted: Published on January 3rd, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/t9s7xm/how_selegiline) has announced the addition of the "How Selegiline ((-)-Deprenyl) Slows Brain Aging" book to their offering. This e-book is a reference on Selegiline ((-)-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. ((-)-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyramine but inhibited it. The compound could be combined with levodopa in Parkinson's disease without signs of hypertensive reactions. The DATATOP study in the USA revealed that (-)-deprenyl delayed the onset of disability associated with early, otherwise untreated Parkinson's disease. The age-related decay of the supply of the brain with phenylethylamine (PEA), due to the progressive increase of MAO-B activity in the aging brain, and dopamine, due to the better than average decline of the dopaminergic neuronal activity during the postdevelopmental phase of life, are irresistible biochemical lesions of aging. The … Continue reading

Posted in Parkinson's Treatment | Comments Off on Research and Markets: How Selegiline ((-)-Deprenyl) Slows Brain Aging

No need for routine repeated CT scans after mild head trauma, study suggests

Posted: Published on January 3rd, 2013

Jan. 3, 2013 When initial computed tomography (CT) scans show bleeding within the brain after mild head injury, decisions about repeated CT scans should be based on the patient's neurological condition, according to a report in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The study questions the need for routinely obtaining repeated CT scans in patients with mild head trauma. "The available evidence indicates that it is unnecessary to schedule a repeat CT scan after mild head injury when patients are unchanged or improving neurologically," according to the study by Dr. Saleh Almenawer and colleagues of McMaster University, Hamilton, Ont., Canada. Are Repeated Scans Necessary after Mild Head Trauma? In a review of their hospital's trauma database, the researchers identified 445 adult patients with mild head injury who had evidence of intracranial hemorrhage (ICH) -- bleeding within the brain -- on an initial CT scan. In many trauma centers, it's standard practice to schedule a second CT scan within 24 hours after ICH is detected, to make sure that the bleeding has not progressed. To evaluate the need for routine repeated scans, Dr. Almenawer and colleagues looked at how many patients needed surgery or … Continue reading

Posted in Brain Injury Treatment | Comments Off on No need for routine repeated CT scans after mild head trauma, study suggests

Former Councilwoman Pushes for Further Brain Injury Research

Posted: Published on January 3rd, 2013

TWIN FALLS In three months, a former Twin Falls city councilwoman traveled more than 8,000 miles to raise awareness about brain injuries. Pam Dowd went to more than 20 states, visiting brain injury rehabilitation centers and families of patients recovering from brain injuries. The Boise resident, who lived in Twin Falls for more than 30 years, left on Sept. 22 and traveled across the country in a 34-foot motorhome. Now that shes back from her cross-country trip, Dowd is working to form a nonprofit organization called Brennas Hope Foundation. Dowds daughter, Brenna, died in 2011 at age 28. She suffered a medically unexplained anoxic brain injury in May 2010 after retina repair surgery. We fought for her recovery for 16 months, Dowd said. There was a time when Brenna could walk using a LiteGait machine. But flu season hit, and she couldnt leave her room. Dowd said the paperwork made it look like her daughter wasnt progressing, so she was cut off from therapy. Brenna suffered a sudden cardiac arrest and spent five days at a hospital. Read more: Former Councilwoman Pushes for Further Brain Injury Research … Continue reading

Posted in Brain Injury Treatment | Comments Off on Former Councilwoman Pushes for Further Brain Injury Research

No need for routine repeated CT scans after mild head trauma, reports neurosurgery

Posted: Published on January 3rd, 2013

Public release date: 3-Jan-2013 [ | E-mail | Share ] Contact: Connie Hughes Connie.Hughes@wolterskluwer.com 646-674-6348 Wolters Kluwer Health Philadelphia, Pa. (January 3, 2013) When initial computed tomography (CT) scans show bleeding within the brain after mild head injury, decisions about repeated CT scans should be based on the patient's neurological condition, according to a report in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. The study questions the need for routinely obtaining repeated CT scans in patients with mild head trauma. "The available evidence indicates that it is unnecessary to schedule a repeat CT scan after mild head injury when patients are unchanged or improving neurologically," according to the study by Dr. Saleh Almenawer and colleagues of McMaster University, Hamilton, Ont., Canada. Are Repeated Scans Necessary after Mild Head Trauma? In a review of their hospital's trauma database, the researchers identified 445 adult patients with mild head injury who had evidence of intracranial hemorrhage (ICH)bleeding within the brainon an initial CT scan. In many trauma centers, it's standard practice to schedule a second CT scan within 24 hours after ICH … Continue reading

Posted in Brain Injury Treatment | Comments Off on No need for routine repeated CT scans after mild head trauma, reports neurosurgery

Hillary Clinton leaves hospital after treatment for blood clot in head

Posted: Published on January 3rd, 2013

U.S. Secretary of State Hillary Rodham Clinton was released from a New York hospital on Wednesday, three days after doctors discovered a blood clot in her head. Ms. Clintons medical team advised her Wedneday evening that she was making good progress on all fronts and said they are confident she will fully recover, said Clinton spokesman Philippe Reines. Doctors had been treating Ms. Clinton with blood thinners to dissolve a clot in a vein that runs through the space between the brain and the skull behind the right ear. Shes eager to get back to the office, Mr. Reines said in a statement, adding that the secretary and her family are grateful for the excellent care she received at New York-Presbyterian Hospital. Mr. Reines said details of when Ms. Clinton will return to work will be clarified in the coming days. Ms. Clinton had been in the hospital since Sunday, when doctors discovered the clot during a follow-up exam stemming from a concussion she suffered earlier in December. While at home battling a stomach virus, Ms. Clinton had fainted, fallen and struck her head, a spokesman said. Grateful my Mom discharged from the hospital and is heading home, the secretarys … Continue reading

Posted in MS Treatment | Comments Off on Hillary Clinton leaves hospital after treatment for blood clot in head

Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice

Posted: Published on January 3rd, 2013

TACOMA, Wash., Jan. 3, 2013 /PRNewswire/ --Results from a collaborative project between Revalesio and Dr. Kalipada Pahan at Rush University showed remarkable therapeutic activity of Revalesio's novel therapeutic RNS60 in a mouse model of multiple sclerosis (MS). In a study recently published in the journal PLOS ONE, RNS60 halted disease progression (as measured by progressive limb paralysis), prevented inflammation in the brain and spinal column while also protecting against demyelination, a process that makes nerve cells lose their protective covering. The research demonstrated that administration of RNS60 - either at early disease onset or late at the relapsing phase - halted disease progression. Animals treated with RNS60 were protected from infiltration of inflammatory cells to the central nervous system, and thus had a significant preservation of the protective nerve covering (myelin). The full details of the study can be found in the journal PLOS ONE (Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline - December 20, 2012). The study revealed further that RNS60 changed the over-reactive immune response associated with MS through increasing the population of regulatory T cells, which have protective function, while reducing the number of inflammatory … Continue reading

Posted in MS Treatment | Comments Off on Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice

Page 5,912«..1020..5,9115,9125,9135,914..5,9205,930..»